Fny Managed Accounts Has Decreased Johnson & Johnson Ord (Call) (JNJ) Stake; BCB Bancorp (BCBP) Has 2.46 Sentiment

May 23, 2018 - By Vivian Park

Johnson & Johnson (NYSE:JNJ) Logo

Fny Managed Accounts Llc decreased Johnson & Johnson Ord (Call) (JNJ) stake by 99.46% reported in 2017Q4 SEC filing. Fny Managed Accounts Llc sold 14,044 shares as Johnson & Johnson Ord (Call) (JNJ)’s stock declined 9.21%. The Fny Managed Accounts Llc holds 76 shares with $10,000 value, down from 14,120 last quarter. Johnson & Johnson Ord (Call) now has $329.66B valuation. The stock decreased 0.65% or $0.81 during the last trading session, reaching $122.91. About 7.17 million shares traded or 6.04% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 23, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

BCB Bancorp Inc (BCBP) investors sentiment decreased to 2.46 in 2017 Q4. It’s down -0.98, from 3.44 in 2017Q3. The ratio worsened, as 32 investment professionals increased or opened new positions, while 13 trimmed and sold stakes in BCB Bancorp Inc. The investment professionals in our database now possess: 4.83 million shares, down from 9.72 million shares in 2017Q3. Also, the number of investment professionals holding BCB Bancorp Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 7 Reduced: 6 Increased: 22 New Position: 10.

Since January 1, 0001, it had 2 insider buys, and 0 selling transactions for $23,550 activity.

BCB Bancorp, Inc. operates as the holding firm for BCB Community Bank, a state chartered commercial bank that provides banking services and products to businesses and individuals in the United States. The company has market cap of $243.16 million. The firm offers deposit products, including savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit, individual retirement accounts, and term certificate accounts. It has a 20.67 P/E ratio. It also provides loans, such as commercial and multi-family real estate loans, one-to four-family mortgage loans, home equity loans and home equity lines of credit, construction loans, consumer loans, commercial business loans, and small business administration lending services.

Analysts await BCB Bancorp, Inc. (NASDAQ:BCBP) to report earnings on July, 16. They expect $0.23 EPS, down 11.54% or $0.03 from last year’s $0.26 per share. BCBP’s profit will be $3.61 million for 16.85 P/E if the $0.23 EPS becomes a reality. After $0.29 actual EPS reported by BCB Bancorp, Inc. for the previous quarter, Wall Street now forecasts -20.69% negative EPS growth.

Seidman Lawrence B holds 1.57% of its portfolio in BCB Bancorp, Inc. for 142,223 shares. Pl Capital Advisors Llc owns 112,216 shares or 0.43% of their US portfolio. Moreover, Banc Funds Co Llc has 0.32% invested in the company for 470,000 shares. The Missouri-based Kennedy Capital Management Inc. has invested 0.09% in the stock. Van Hulzen Asset Management Llc, a California-based fund reported 20,000 shares.

Another recent and important BCB Bancorp, Inc. (NASDAQ:BCBP) news was published by Streetinsider.com which published an article titled: “BCB Bancorp (BCBP) Declares $0.14 Quarterly Dividend; 3.6% Yield” on April 23, 2018.

The stock decreased 1.59% or $0.25 during the last trading session, reaching $15.5. About 15,532 shares traded. BCB Bancorp, Inc. (BCBP) has declined 5.15% since May 23, 2017 and is downtrending. It has underperformed by 16.70% the S&P500.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 101 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Underweight” rating by Alembic given on Friday, July 21. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 7 with “Outperform” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by JP Morgan on Tuesday, January 2. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, October 18. On Monday, February 26 the stock rating was maintained by Jefferies with “Buy”. The firm has “Neutral” rating by Goldman Sachs given on Monday, March 14. Atlantic Securities downgraded the stock to “Sell” rating in Friday, July 21 report. The firm has “Hold” rating by Piper Jaffray given on Tuesday, July 18. The firm has “Buy” rating by Deutsche Bank given on Tuesday, September 29. The rating was maintained by BMO Capital Markets with “Buy” on Monday, July 10.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.05 earnings per share, up 12.02% or $0.22 from last year’s $1.83 per share. JNJ’s profit will be $5.50B for 14.99 P/E if the $2.05 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -0.49% negative EPS growth.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Congo begins Ebola vaccinations” on May 21, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Presents at UBS Health Care Brokers Conference (Transcript)” published on May 21, 2018, Livetradingnews.com published: “Johnson & Johnson (NYSE:JNJ) Heffx Stock Technicals” on May 18, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson: Waiting On The Wave” published on May 11, 2018 as well as 247Wallst.com‘s news article titled: “Johnson & Johnson Commits to Yet Another Dividend Hike” with publication date: April 26, 2018.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts